PubMed

3-day treatment with azithromycin 1.5% eye drops versus 7-day treatment with tobramycin 0.3% for purulent bacterial conjunctivitis: multicentre, randomised and controlled trial in adults and children.

Cochereau I, Meddeb-Ouertani A, Khairallah M, Amraoui A, Zaghloul K, Pop M, Delval L, Pouliquen P, Tandon R, Garg P, Goldschmidt P, Bourcier T.

Br J Ophthalmol. 2007 Apr;91(4):465-9. Epub 2006 Oct 18.PMID: 17050578 [PubMed - indexed for MEDLINE]Related articles

Microbiological efficacy of 3-day treatment with azithromycin 1.5% eye-drops for purulent bacterial conjunctivitis.

Denis F, Chaumeil C, Goldschmidt P, Delval L, Pouliquen P, Cochereau I, Chainier D, De Barbeyrac B.

Eur J Ophthalmol. 2008 Nov-Dec;18(6):858-68.PMID: 18988154 [PubMed - indexed for MEDLINE]Related articles

Phase 3 safety comparisons for 1.0% azithromycin in polymeric mucoadhesive eye drops versus 0.3% tobramycin eye drops for bacterial conjunctivitis.

Protzko E, Bowman L, Abelson M, Shapiro A; AzaSite Clinical Study Group.

Invest Ophthalmol Vis Sci. 2007 Aug;48(8):3425-9.PMID: 17652708 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment of acute bacterial conjunctivitis: 1% fusidic acid viscous drops vs. 0.3% tobramycin drops.

Jackson WB, Low DE, Dattani D, Whitsitt PF, Leeder RG, MacDougall R.

Can J Ophthalmol. 2002 Jun;37(4):228-37; discussion 237.PMID: 12095096 [PubMed - indexed for MEDLINE]Related articles

Clinical cure of bacterial conjunctivitis with azithromycin 1%: vehicle-controlled, double-masked clinical trial.

Abelson MB, Heller W, Shapiro AM, Si E, Hsu P, Bowman LM; AzaSite Clinical Study Group.

Am J Ophthalmol. 2008 Jun;145(6):959-65. Epub 2008 Mar 28.PMID: 18374301 [PubMed - indexed for MEDLINE]Related articles

A clinical comparison of two formulations of tobramycin 0.3% eyedrops in the treatment of acute bacterial conjunctivitis.

Kernt K, Martinez MA, Bertin D, Stroman D, Cupp G, Martínez C, Tirado M, Guasch J; International Tobrex2x Group (Eu).

Eur J Ophthalmol. 2005 Sep-Oct;15(5):541-9.PMID: 16167284 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of short duration azithromycin eye drops versus azithromycin single oral dose for the treatment of trachoma in children: a randomised, controlled, double-masked clinical trial.

Cochereau I, Goldschmidt P, Goepogui A, Afghani T, Delval L, Pouliquen P, Bourcier T, Robert PY.

Br J Ophthalmol. 2007 May;91(5):667-72. Epub 2006 Sep 27.PMID: 17005549 [PubMed - indexed for MEDLINE]Related articles

Topical lomefloxacin 0.3% twice daily versus tobramycin 0.3% in acute bacterial conjunctivitis: A multicenter double-blind phase III study.

Gallenga PE, Lobefalo L, Colangelo L, Della Loggia G, Orzalesi N, Velati P, Bujtar E, Ponte F, Damiani S, Bucci MG, Bonini S, Curatola MR, Palma LA, Bonomi L, Tomazzoli Gerosa L, Pagliarusco A, Milan E, Jauch A.

Ophthalmologica. 1999;213(4):250-7.PMID: 10420109 [PubMed - indexed for MEDLINE]Related articles

Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group.

Hyndiuk RA, Eiferman RA, Caldwell DR, Rosenwasser GO, Santos CI, Katz HR, Badrinath SS, Reddy MK, Adenis JP, Klauss V.

Ophthalmology. 1996 Nov;103(11):1854-62; discussion 1862-3.PMID: 8942881 [PubMed - indexed for MEDLINE]Related articles

[Evaluation of effectiveness and tolerance of treatment with azithromycin 1.5% eye drops in bacterial conjunctivitis]

Ambroziak AM, Szaflik JP, Hapunik A.

Klin Oczna. 2009;111(1-3):46-9. Polish. PMID: 19517846 [PubMed - indexed for MEDLINE]Related articles

A randomized, investigator- masked clinical trial comparing the efficacy and safety of gatifloxacin 0.3% administered BID versus QID for the treatment BID versus QID for the treatment of acute bacterial conjunctivitis of acute bacterial conjunctivitis.

Yee RW, Tepedino M, Bernstein P, Jensen H, Schiffman R, Whitcup SM; Gatifloxacin BID/QID Study Group.

Curr Med Res Opin. 2005 Mar;21(3):425-31.PMID: 15811211 [PubMed - indexed for MEDLINE]Related articles

A phase III, placebo controlled clinical trial of 0.5% levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis.

Hwang DG, Schanzlin DJ, Rotberg MH, Foulks G, Raizman MB; Levofloxacin Bacterial Conjunctivitis Place-controlled Study Group.

Br J Ophthalmol. 2003 Aug;87(8):1004-9.PMID: 12881345 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and safety of besifloxacin ophthalmic suspension 0.6% compared with moxifloxacin ophthalmic solution 0.5% for treating bacterial conjunctivitis.

McDonald MB, Protzko EE, Brunner LS, Morris TW, Haas W, Paterno MR, Comstock TL, Usner DW.

Ophthalmology. 2009 Sep;116(9):1615-1623.e1. Epub 2009 Jul 29.PMID: 19643483 [PubMed - indexed for MEDLINE]Related articles

A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis.

Schwab IR, Friedlaender M, McCulley J, Lichtenstein SJ, Moran CT; Levofloxacin Bacterial Conjunctivitis Active Control Study Group.

Ophthalmology. 2003 Mar;110(3):457-65.PMID: 12623805 [PubMed - indexed for MEDLINE]Related articles

Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: A multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety study.

Karpecki P, Depaolis M, Hunter JA, White EM, Rigel L, Brunner LS, Usner DW, Paterno MR, Comstock TL.

Clin Ther. 2009 Mar;31(3):514-26.PMID: 19393842 [PubMed - indexed for MEDLINE]Related articles

Meta-analysis of six clinical phase III studies comparing lomefloxacin 0.3% eye drops twice daily to five standard antibiotics in patients with acute bacterial conjunctivitis.

Jauch A, Fsadni M, Gamba G.

Graefes Arch Clin Exp Ophthalmol. 1999 Sep;237(9):705-13.PMID: 10447643 [PubMed - indexed for MEDLINE]Related articles

Comparison of single-dose azithromycin and 12-dose, 3-day erythromycin for childhood cholera: a randomised, double-blind trial.

Khan WA, Saha D, Rahman A, Salam MA, Bogaerts J, Bennish ML.

Lancet. 2002 Nov 30;360(9347):1722-7.PMID: 12480424 [PubMed - indexed for MEDLINE]Related articles

Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis.

Langley JM, Halperin SA, Boucher FD, Smith B; Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC).

Pediatrics. 2004 Jul;114(1):e96-101.PMID: 15231980 [PubMed - indexed for MEDLINE]Related articlesFree article

A controlled trial of povidone-iodine to treat infectious conjunctivitis in children.

Isenberg SJ, Apt L, Valenton M, Del Signore M, Cubillan L, Labrador MA, Chan P, Berman NG.

Am J Ophthalmol. 2002 Nov;134(5):681-8.PMID: 12429243 [PubMed - indexed for MEDLINE]Related articles

A comparison of 5-day courses of dirithromycin and azithromycin in the treatment of acute exacerbations of chronic obstructive pulmonary disease.

Castaldo RS, Celli BR, Gomez F, LaVallee N, Souhrada J, Hanrahan JP.

Clin Ther. 2003 Feb;25(2):542-57.PMID: 12749513 [PubMed - indexed for MEDLINE]Related articles